Sleep disorders and addictions: Impact on quality of life and relapse vulnerability | Troubles du sommeil et addictions : impact sur la qualité de vie et le risque de rechute

Mélina Fatseas, Charlotte Kervran, Marc Auriacombe
La Presse Médicale. 2016-12-01; 45(12): 1164-1169
DOI: 10.1016/j.lpm.2016.01.022

PubMed
Read on PubMed



1. Presse Med. 2016 Dec;45(12 Pt 1):1164-1169. doi: 10.1016/j.lpm.2016.01.022. Epub
2016 Mar 9.

[Sleep disorders and addictions: Impact on quality of life and relapse
vulnerability].

[Article in French]

Fatseas M(1), Kervran C(2), Auriacombe M(3).

Author information:
(1)Université de Bordeaux, 33076 Bordeaux cedex, France; SANPsy CNRS USR 3413,
Addiction psychiatry Team, 33076 Bordeaux, France; Pôle d’Addictologie, CH Ch.
Perrens, CHU de Bordeaux, 33076 Bordeaux, France. Electronic address:
.
(2)Université de Bordeaux, 33076 Bordeaux cedex, France; SANPsy CNRS USR 3413,
Addiction psychiatry Team, 33076 Bordeaux, France; Pôle d’Addictologie, CH Ch.
Perrens, CHU de Bordeaux, 33076 Bordeaux, France.
(3)Université de Bordeaux, 33076 Bordeaux cedex, France; SANPsy CNRS USR 3413,
Addiction psychiatry Team, 33076 Bordeaux, France; Pôle d’Addictologie, CH Ch.
Perrens, CHU de Bordeaux, 33076 Bordeaux, France. Electronic address:
.

There is a bidirectional association between sleep disorders and addiction. Sleep
problems negatively impact the quality of life of subjects with addictions
(psychological state, pain perception, drug use). Sleep disorders are associated
with a higher risk of relapse among sujects with addiction. The association
between sleep disorders and relapse may be related to poor quality of life or to
a higher level of craving. Maintaining abstinence and reducing craving episodes
among subjects with addiction is the first-line treatment to reduce sleep
disorders. Specific interventions focused on sleep disorders are needed when
sleep disorders persist during abstinence and may improve global addiction
outcome.

Copyright © 2016 Elsevier Masson SAS. All rights reserved.

DOI: 10.1016/j.lpm.2016.01.022
PMID: 26970937 [Indexed for MEDLINE]

Know more about